ELANCO AH0315 RUMENSIN CAPSULE

Land: Australien

Sprache: Englisch

Quelle: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Wirkstoff:

MONENSIN AS MONENSIN SODIUM

Verfügbar ab:

ELANCO AUSTRALASIA PTY LTD

INN (Internationale Bezeichnung):

monensin as sodium(32g/Cp)

Darreichungsform:

MISC. INTRA RUMINAL DEVICE

Zusammensetzung:

MONENSIN AS MONENSIN SODIUM ANTIPROTOZOAL Active 32.0 g/Cp

Einheiten im Paket:

10 capsule

Klasse:

VM - Veterinary Medicine

Hergestellt von:

ELANCO ANIMAL HEALTH

Therapiegruppe:

CATTLE | DAIRY CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BREEDERS | BUFFALO | BULL | BULLOCK | CALF | CALVES | COW | D

Therapiebereich:

ALIMENTARY SYSTEM

Anwendungsgebiete:

BLOAT | IMPROVEMENT OF MILK PRODUCTION | KETOSIS | PRODUCTIVITY IMPROVEMENTS | ACETONAEMIA | BLOATED | COLIC | ELEVATED KETONES | FROTHY BLOAT | GAS COLIC | IMPROVING FEED EFFICIENCY | INCREASING RATE OF WEIGHT GAIN | LEGUME BLOAT | NON-CLINICAL KETOSIS | WEIGHT GAIN

Produktbesonderheiten:

Poison schedule: 5; Withholding period: WHP: Meat: Nil. Milk: Nil.; Host/pest details: CATTLE: [BLOAT, KETOSIS, PRODUCTIVITY IMPROVEMENTS]; DAIRY CATTLE: [BLOAT, IMPROVEMENT OF MILK PRODUCTION, KETOSIS]; Controlled release capsule for bloat control, production improvement, and treatment and prevention of sub-clinical ketosis in beef and dairy cattle.This product is contraindicated for use in cattle of less than 200kg liveweight. Dogs and horses must not be allowed access to the capsule since ingestion of the rumensin core may be fatal in these species.

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2023-07-01

Gebrauchsinformation

ELANCO AH0315 RUMENSIN CAPSULE
54669/123248
Product Name:
APVMA Approval No:
Label Name:
ELANCO AH0315 RUMENSIN CAPSULE
Signal Headings:
CAUTION
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
32 g/Capsule MONENSIN AS MONENSIN SODIUM
Claims:
Controlled Release Capsule for Bloat Control, Production Improvement
and Treatment and
Prevention of Sub-Clinical Ketosis in Beef and Dairy Cattle.
As an aid in reducing bloat in pasture fed cattle.
For increased weight gain in beef cattle depending on the nutritional
status of the pasture.
For increased milk production in dairy cows.
For treatment and prevention of sub-clinical ketosis in beef and dairy
cattle.
Net Contents:
10 capsule
Directions for Use:
Restraints:
Contraindications:
This product is contra-indicated for use in cattle of less than 200kg
live weight.
Dogs and horses must not be allowed access to the capsule since
ingestion of the
Rumensin core may be fatal in these species.
Precautions:
Hold the treated cattle in the yards for at least one hour after
administration of the capsule
to observe failure to swallow (spit up). If spit up is observed
identify the animal by matching
the animal identification number with the number embossed on the
capsule (each capsule
has an individual embossed number for identification purposes) and
redose with an
undamaged capsule. In case of spit ups during the bloat season, match
capsule number
with animal identification number, remove the animal from the pasture
and redose with an
undamaged capsule. Retreated animals may be re-introduced to the
bloat-causing pasture
one week after treatment. RLP APPROVED
Recheck all cattle 3-4 days after dosing for capsule lodgement. Signs
of lodgement are:
coughing, drooling, off-feed and ill-thrift. If lodgement is suspected
contact your local
veterinarian immediately. Small heifers dosed with the capsule may
initially develop
scouring.
Side Effects:
Dosage and
Administration:
Each Rumensin Capsule will provide an effective daily dose of monensin
for an average

Fachinformation

 Page 1  

MATERIAL SAFETY DATA SHEET 
RUMENSIN CAPSULE 
AH0315 

Revision  1.1  22 November 2006 

STATEMENT OF HAZARDOUS NATURE: 
The Rumensin Capsule is not considered hazardous when intact. 
The following Statement of Hazardous Nature refers to the core
material which contains 
monensin: 
"Hazardous according to criteria of Worksafe Australia" 
Toxic; R25 Toxic if swallowed. 
Irritant; R37/38 Irritating to respiratory system and skin. 
Irritant; R41 Risk of serious damage to eyes. 

Company Name and Address: 
Elanco Animal Health 
A Division of Eli Lilly Australia Pty Ltd 
A.B.N. 39 000 233 992 
112 Wharf Road, West Ryde, N.S.W. 2114, Australia 

Contact Numbers: 
Tel: 
[phone] 
Fax: 
[phone] 

EMERGENCY TELEPHONE NUMBERS: 
Elanco Animal Health: 
1800 226 324 (Toll free) 
OR 
Poisons Information Centre: 
131126 (Australia-wide) 

24 hour emergency contact number, CHEMWATCH 1800 039 008 ( spills
and accidents) 

SECTION 1 - IDENTIFICATION 

Product Name: ElancoAH0315 Rumensin Capsule 

Other Names: Rumensin CRC, Rumensin Controlled Release Capsule,
Rumensin Anti Bloat 
Capsule 

Manufacturer’s Product Code: AH0315 

UN Number: None allocated 

 Page 2  
Dangerous Goods Class/Subsidiary Risk: None allocated 

Hazchem Code: None allocated 

Poisons Schedule Number: S5 

Pack Size and Container Type: Box of 10 capsules 

USE: 

Major Recommended Uses: As an aid in reducing bloat in pasture fed
cattle.  For increased 
weight gain in beef cattle, depending on the nutritional status of the
pasture.  For increased 
milk production in dairy cattle.  For treatment and prevention of
sub-clinical ketosis in beef 
and dairy cattle. 

Major Recommended Method(s) of Application: Oral 

SECTION 2 - COMPOSITION / INFORMATION ON INGREDIENTS 

Ingredient       

CAS     
Concentration % 
Monensin Sodium      

22373-78-0    
43 
Hexaglycerol Distearate   

61725-93-7  �